Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
24.04B | 18.57B | 15.94B | 13.57B | 12.33B | 11.06B |
Gross Profit | |||||
7.56B | 6.05B | 5.03B | 4.35B | 3.70B | 2.93B |
EBIT | |||||
3.91B | 2.84B | 2.07B | 1.68B | 1.11B | 729.68M |
EBITDA | |||||
4.37B | 3.34B | 2.57B | 2.05B | 1.47B | 1.25B |
Net Income Common Stockholders | |||||
1.97B | 1.48B | 1.09B | 976.00M | 633.14M | 470.36M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
11.39B | 8.78B | 6.93B | 6.74B | 4.82B | 4.87B |
Total Assets | |||||
24.14B | 19.55B | 16.44B | 14.19B | 11.76B | 10.66B |
Total Debt | |||||
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Debt | |||||
-11.39B | -8.78B | -6.93B | -6.73B | -4.74B | -4.87B |
Total Liabilities | |||||
15.83B | 12.41B | 9.79B | 8.79B | 7.31B | 5.85B |
Stockholders Equity | |||||
7.31B | 6.38B | 6.19B | 5.13B | 4.29B | 4.62B |
Cash Flow | Free Cash Flow | ||||
0.00 | 2.81B | 817.00M | 2.01B | 1.87B | -278.14M |
Operating Cash Flow | |||||
0.00 | 2.99B | 1.46B | 2.57B | 1.98B | 128.87M |
Investing Cash Flow | |||||
0.00 | -604.00M | -1.07B | -459.82M | -1.66B | -686.00M |
Financing Cash Flow | |||||
0.00 | -586.00M | -149.00M | -191.60M | -403.62M | 104.64M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥3.60T | 24.41 | 1.36% | 5.67% | 39.04% | ||
76 Outperform | $741.91B | 32.64 | 14.25% | 1.28% | 6.67% | 114.29% | |
76 Outperform | ¥75.67B | 44.95 | 0.79% | 36.56% | 47.47% | ||
64 Neutral | ¥521.34B | 70.88 | 0.79% | 7.67% | -34.27% | ||
61 Neutral | $14.56B | 5.82 | -4.02% | 6.41% | 2.72% | -31.67% | |
60 Neutral | $224.61B | ― | -9.01% | <0.01% | 20.96% | -222.06% | |
52 Neutral | ¥7.63B | ― | 1.13% | -7.72% | -105.91% |